Full-Time
Confirmed live in the last 24 hours
Develops durable genetic treatments for diseases
Mid, Senior
Cambridge, MA, USA
You match the following Generation Bio's candidate preferences
Employers are more likely to interview you if you match these preferences:
Generation Bio focuses on developing genetic treatments for both rare and common diseases. Their main product is based on a non-viral genetic medicine platform that includes iqDNA, which is designed to be immune-quiet, and ctLNP, a delivery system that targets specific cells. This platform allows for the delivery of large amounts of genetic material to particular tissues, aiming for long-lasting effects from a single dose. They use a unique manufacturing process called rapid enzymatic synthesis (RES) that enables them to produce these treatments at scale, potentially reaching hundreds of millions of doses. Unlike many competitors, Generation Bio emphasizes the ability to redose treatments to adjust how much genetic material is expressed in patients. Their goal is to make genetic medicine more accessible and to address significant medical needs for a wide range of diseases.
Company Stage
IPO
Total Funding
$252.9M
Headquarters
Cambridge, Massachusetts
Founded
2016
Help us improve and share your feedback! Did you find this helpful?